SCHEMBL1521201

SCHEMBL1521201

Cc1nccc2cc(O)c(O)cc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.50
CYP1A2 P05177 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
ALOX15 P16050 1/20 0.49
CASP1 P29466 1/20 0.49
CASP7 P55210 1/20 0.49
HSD17B10 Q99714 1/20 0.49
IGFBP3 P17936 1/20 0.47
RAC1 P63000 6/20 0.39
CDC42 P60953 4/20 0.39
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
GAA P10253 1/20 0.38
HPGD P15428 1/20 0.38
STAT3 P40763 1/20 0.38
JAK3 P52333 1/20 0.36
PDE3B Q13370 3/20 0.35
PDE3A Q14432 3/20 0.35
PRMT3 O60678 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24925225 0.82 LMNA (0.42) CYP2A6CYP1A2CYP2D6CYP2C9ALOX15
SCHEMBL21133778 0.78 CYP2A6 (0.54) CYP2A6CYP1A2CYP2D6HSD17B10KDM4E
SCHEMBL29431723 0.78 CYP2A6 (0.53) CYP2A6CASP1CASP7KDM4EALDH1A1
SCHEMBL1563592 0.78 CYP2A6 (0.53) CYP2A6CASP1CASP7KDM4EALDH1A1
SCHEMBL1562651 0.78 CYP2A6 (0.53) CYP2A6CYP1A2CASP1CASP7ALDH1A1
Bromide SCHEMBL21436095 0.76 CYP2A6 (0.52) CYP2A6CYP1A2CASP1CASP7ALDH1A1
SCHEMBL7514592 0.75 CYP2A6 (0.67) CYP2A6CYP1A2CYP2D6HSD17B10KDM4E
SCHEMBL26873044 0.73 CYP2A6 (0.64) CYP2A6CYP1A2CYP2D6ALOX15CASP1
SCHEMBL8404535 0.72 CYP2A6 (0.57) CYP2A6CYP1A2KDM4EALDH1A1UHRF1
SCHEMBL2757278 0.72 CYP2A6 (0.57) CYP2A6CYP1A2HSD17B10KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150299223-A1 2-SUBSTITUTED CEPHEM COMPOUNDS GLAXO GROUP LTD (GB) 2015-10-22 US disclosed
US-20130289083-A1 IDO Inhibitors NEWLINK GENETICS CORPORATION 2013-10-31 US disclosed
US-20130289083-A1 IDO Inhibitors NEWLINK GENETICS CORPORATION 2013-10-31 US disclosed
US-20110053941-A1 IDO Inhibitors NEWLINK GENETICS (US) 2011-03-03 US disclosed
US-20110053941-A1 IDO Inhibitors NEWLINK GENETICS (US) 2011-03-03 US disclosed
US-20110053941-A1 IDO Inhibitors NEWLINK GENETICS (US) 2011-03-03 US disclosed
EP-0373216-A1 CEPHALOSPORIN COMPOUNDS OR THEIR SALTS, PROCESS FOR THEIR PREPARATION, AND PARMACEUTICAL COMPOSITIONS TEIJIN LIMITED (JP) 1990-06-20 EP disclosed
EP-0347459-A1 CEPHALOSPORIN COMPOUNDS OR THEIR SALTS, PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS TEIJIN LIMITED (JP) 1989-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110053941-A1 IDO Inhibitors IDO1, IDO2, INMT CYP2A6 718/4885CYP1A2 410/4885CYP2D6 322/4885
US-20130289083-A1 IDO Inhibitors IDO1, IDO2, INMT CYP2A6 776/4885CYP1A2 450/4885CYP2D6 324/4885
US-20150299223-A1 2-SUBSTITUTED CEPHEM COMPOUNDS CEP170, ABL1, CEPT1 CYP2A6 1610/4885CYP1A2 976/4885CYP2D6 1194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.